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Vectorial vaccines are predicted to yield novel therapeu-
tic and protective approaches. They consist of recombi-
nant live carriers that express antigen from an unrelated
pathogen in the recipient. Promising viral carriers are
host-restricted pox viruses that trigger a strong immune
response without ability to replicate in the human
organism. A block in replication is an important safety
f e a t u r et h a ta l l o w sa p p l i c a t i o ne v e ni ni m m u n o c o m p r o -
mized recipients. However, with this type of attenuation
there is not even limited amplification of the vector at
the site of infection and therefore very high numbers of
infectious units have to be given per dose for full effi-
cacy. Hence, if such vectors are to be used in global vac-
cine programs highly efficient production processes will
be required. Furthermore, to combat diseases such as
AIDS, hepatitis C, tuberculosis, or malaria with these
vectors, millions of the concentrated vaccine units will
have to be provided annually. Any production process
therefore should also be scalable and preferrably trans-
ferrable to newly industrialized countries. Latter require-
ment demands a robust process independent of the
complex logistics and uncertainties associated with pri-
mary chicken cells, the current industrial substrate for
these pox viruses and certain other vectors.
We believe that we have solved most of the upstream
challenges with a chemically defined suspension culture
production process for three disparate members of the
highly attenuated poxviruses [1]: modified vaccinia
Ankara (MVA), fowlpoxvirus (FPV) and canarypoxvirus
ALVAC. The process is independent of primary material
and based on the continuous duck suspension cell line
AGE1.CR specifically created as a vaccine substrate [2].
In contrast to production of influenza virus that read-
ily replicates in the cell proliferation medium [3], devel-
opment of a production process for poxviruses was
surprisingly complicated and involves media formula-
tions matched to two distinct phases, cell proliferation
and virus production. Our process was adjusted to the
different kinetics and requirements of the three exam-
ined viruses, and was studied in Wave and disposable
bioreactors up to 50 L scale. For MVA, titers in the
c r u d el y s a t ew i t h o u ta n yp r o c e s s i n gr e l i a b l ye x c e e dt h e
critical threshold of 10
8 pfu/mL and often are in the
range of 5 × 10
8 to 2 × 10
9 pfu/mL.
One hallmark of the biphasic process described here is
controlled formation of suspension cell aggregates at the
transition from cell proliferation to virus production.
Such aggregate formation was achieved with distinct
chemically defined media harmonized such that a highly
efficient, robust and industrial biphasic processes was
obtained that does not require perfusion, medium repla-
cement or microcarriers.
In addition to poxviruses, this approach was successful
in production of an unrelated RNA vector and also for
this reason we believe that we have developed a more
general principle for scalable production of viruses that
may benefit from cell-to-cell contacts: In the back-
ground of the AGE1.CR cell lines, packaging cells were
created for SIN/VEE-chimeric alphavirus replicons [4].
The packaging cells were transfected for stable trans-
complementation of envelope and capsid proteins from
separate expression cassettes. Production of replicons
was efficient using adherent (serum-dependent) cultures
but only moderately efficient with suspension cultures
of the packaging cells. After transfer and optimization of
the pox virus production process to replicon-induced
packaging cell cultures (shown in figure 1) we obtained
yields beyond 10
8 pfu/mL.
Appearance of suspension packaging cells just prior to
infection and at various time points during virus produc-
tion is shown in (A). Note induction of aggregates in pre-
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with peak titers 24 h to 48 h post induction.
In summary, superior yields were obtained for unre-
lated viral vectors using separate chemically defined
media for proliferation and virus production. The media
are matched to allow highly efficient, robust and indus-
trial biphasic processes that do not require perfusion or
medium replacement.
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Figure 1 Biphasic process adapted to alphavirus replicons.
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